Avinger (AVGR) Competitors $0.47 0.00 (0.00%) As of 02/20/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends AVGR vs. CTCX, NUWE, CHEK, TNON, SINT, TTOO, HSCS, AMIX, NDRA, and GMVDFShould you be buying Avinger stock or one of its competitors? The main competitors of Avinger include Carmell (CTCX), Nuwellis (NUWE), Check-Cap (CHEK), Tenon Medical (TNON), Sintx Technologies (SINT), T2 Biosystems (TTOO), Heart Test Laboratories (HSCS), Autonomix Medical (AMIX), ENDRA Life Sciences (NDRA), and G Medical Innovations (GMVDF). These companies are all part of the "medical equipment" industry. Avinger vs. Carmell Nuwellis Check-Cap Tenon Medical Sintx Technologies T2 Biosystems Heart Test Laboratories Autonomix Medical ENDRA Life Sciences G Medical Innovations Avinger (NASDAQ:AVGR) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, community ranking, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings. Does the media favor AVGR or CTCX? In the previous week, Avinger had 3 more articles in the media than Carmell. MarketBeat recorded 3 mentions for Avinger and 0 mentions for Carmell. Carmell's average media sentiment score of 0.00 beat Avinger's score of -0.36 indicating that Carmell is being referred to more favorably in the news media. Company Overall Sentiment Avinger Neutral Carmell Neutral Do insiders & institutionals believe in AVGR or CTCX? 18.3% of Avinger shares are held by institutional investors. Comparatively, 24.2% of Carmell shares are held by institutional investors. 42.8% of Avinger shares are held by company insiders. Comparatively, 29.0% of Carmell shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has more risk and volatility, AVGR or CTCX? Avinger has a beta of 1.09, indicating that its share price is 9% more volatile than the S&P 500. Comparatively, Carmell has a beta of 0.41, indicating that its share price is 59% less volatile than the S&P 500. Do analysts recommend AVGR or CTCX? Avinger presently has a consensus target price of $5.00, indicating a potential upside of 954.85%. Given Avinger's stronger consensus rating and higher probable upside, analysts clearly believe Avinger is more favorable than Carmell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Avinger 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Carmell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in AVGR or CTCX? Avinger received 393 more outperform votes than Carmell when rated by MarketBeat users. CompanyUnderperformOutperformAvingerOutperform Votes39356.55% Underperform Votes30243.45% CarmellN/AN/A Is AVGR or CTCX more profitable? Carmell has a net margin of 0.00% compared to Avinger's net margin of -261.06%. Carmell's return on equity of -217.50% beat Avinger's return on equity.Company Net Margins Return on Equity Return on Assets Avinger-261.06% -5,527.11% -123.25% Carmell N/A -217.50%-50.22% Which has preferable earnings & valuation, AVGR or CTCX? Carmell has lower revenue, but higher earnings than Avinger. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAvinger$7.65M0.21-$18.32M-$11.06-0.04CarmellN/AN/A-$15.44MN/AN/A SummaryAvinger beats Carmell on 8 of the 14 factors compared between the two stocks. Get Avinger News Delivered to You Automatically Sign up to receive the latest news and ratings for AVGR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVGR vs. The Competition Export to ExcelMetricAvingerSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.57M$4.59B$5.77B$8.98BDividend YieldN/A39.91%4.78%3.85%P/E Ratio-0.0431.4526.4618.82Price / Sales0.2150.79453.2580.30Price / CashN/A51.2344.0437.47Price / Book-0.106.577.634.64Net Income-$18.32M$90.13M$3.18B$245.69M7 Day PerformanceN/A-2.20%-1.91%-2.66%1 Month Performance-16.84%-2.17%-0.19%-2.15%1 Year Performance-86.69%15.26%16.70%12.90% Avinger Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVGRAvinger3.0758 of 5 stars$0.47flat$5.00+954.9%N/A$1.57M$7.65M-0.0470Analyst ForecastCTCXCarmellN/A$0.28-9.2%N/A-92.2%$5.90MN/A0.0014NUWENuwellis1.8159 of 5 stars$1.33+4.7%$17.00+1,178.2%-94.0%$5.81M$8.86M-0.0170News CoverageGap UpCHEKCheck-Cap0.4493 of 5 stars$0.90-2.2%N/A-68.1%$5.27MN/A-0.3080Analyst ForecastTNONTenon Medical1.6892 of 5 stars$1.46-2.3%$5.50+278.0%+23.0%$4.57M$2.93M-0.058SINTSintx Technologies1.0106 of 5 stars$3.06-5.6%N/A-82.2%$4.10M$2.63M-0.0640News CoverageGap DownTTOOT2 Biosystems1.9659 of 5 stars$0.19-7.4%$5.00+2,472.0%-96.8%$4.09M$7.68M0.00180Analyst ForecastNews CoverageGap UpHigh Trading VolumeHSCSHeart Test Laboratories2.4753 of 5 stars$3.59-5.5%$13.50+276.0%-69.2%$3.52M$20,000.00-0.4510AMIXAutonomix Medical1.8711 of 5 stars$2.72+0.7%$28.00+929.4%-96.2%$3.13MN/A-0.171News CoverageNDRAENDRA Life Sciences2.344 of 5 stars$4.98-5.3%$700,000.00+14,056,124.9%-100.0%$2.67MN/A-0.0120GMVDFG Medical InnovationsN/AN/AN/A-99.3%$2.60M$4.42M0.0072 Related Companies and Tools Related Companies Carmell Alternatives Nuwellis Alternatives Check-Cap Alternatives Tenon Medical Alternatives Sintx Technologies Alternatives T2 Biosystems Alternatives Heart Test Laboratories Alternatives Autonomix Medical Alternatives ENDRA Life Sciences Alternatives G Medical Innovations Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AVGR) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avinger, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avinger With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
